Združene države Amerike - angleščina - NLM (National Library of Medicine)

prasco laboratories - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - atovaquone 250 mg - atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated p. falciparum malaria. atovaquone and proguanil hydrochloride have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. risk summary available data from published literature and postmarketing experience with use of atovaquone and proguanil hydrochloride in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. the proguanil component of atovaquone and proguanil hydrochloride tablets acts to inhibit parasitic dihydrofolate reductase; however, pregnant women and females of reproductive potential should continue fola

Združene države Amerike - angleščina - NLM (National Library of Medicine)

bryant ranch prepack - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - atovaquone 250 mg - atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated p. falciparum malaria. atovaquone and proguanil hydrochloride have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. risk summary available data from published literature and postmarketing experience with use of atovaquone and proguanil hydrochloride in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. the proguanil component of atovaquone and proguanil hydrochloride tablets acts to inhibit parasitic dihydrofolate reductase; however, pregnant women and females of reproductive potential should continue fola

Združene države Amerike - angleščina - NLM (National Library of Medicine)

a-s medication solutions - atovaquone (unii: y883p1z2lt) (atovaquone - unii:y883p1z2lt), proguanil hydrochloride (unii: r71y86m0wt) (proguanil - unii:s61k3p7b2v) - atovaquone 250 mg - atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated p. falciparum malaria. atovaquone and proguanil hydrochloride have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance. risk summary available data from published literature and postmarketing experience with use of atovaquone and proguanil hydrochloride in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. the proguanil component of atovaquone and proguanil hydrochloride tablets acts to inhibit parasitic dihydrofolate reductase; however, pregnant women and females of reproductive potential should continue fola

Malta - angleščina - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - mefloquine - tablet - mefloquine 250 milligram(s) - antiprotozoals

Malta - angleščina - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - mefloquine - tablet - mefloquine 250 mg - antiprotozoals

Tanzanija - angleščina - Tanzania Medicinces & Medical Devices Authority

cipla limited, india - artesunate , mefloquine - tablets - 100mg + 200mg

Malta - angleščina - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - mefloquine - coated tablet - mefloquine 250 mg - antiprotozoals

Kenija - angleščina - Pharmacy and Poisons Board

acino pharma ag birsweg 2 liesberg basel ��� land - artesunate 100 mg mefloquine 125 mg - film-coated tablet - mefloquine hydrochloride micronized 1375000 - antimalarial antiprotozoals: plain artemisininand

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mefloquine hydrochloride 250mg; pyrimethamine 500mg; sulfadoxine 25mg - tablet - 250mg/500mg/25mg - active: mefloquine hydrochloride 250mg pyrimethamine 500mg sulfadoxine 25mg

Indija - angleščina - Central Drugs Standard Control Organization

lupin - mefloquine hcl. - tab - 250mg - 5